By Lina Saigol and Paul Clarke
The world’s largest investment banks made more money in fees during the first nine months of the year than at any point since before the 2008 financial crisis, fueled by emergency fundraisings, initial public offerings and a rash of mergers and acquisitions activity.
Investment banking fees soared to around $64 billion in the first three quarters of 2020, the most lucrative start to the year for the sector since 2007, when banks were riding high at the top of the last M&A cycle and a year before Lehman Brothers collapsed.
Five banks — JPMorgan /zigman2/quotes/205971034/composite JPM +0.90% , Goldman Sachs /zigman2/quotes/209237603/composite GS -0.47% , Bank of America /zigman2/quotes/200894270/composite BAC +0.68% , Morgan Stanley /zigman2/quotes/209104354/composite MS +0.06% and Citigroup /zigman2/quotes/207741460/composite C +0.66% — accounted for around a third of that, collectively raking in fees of $19.8 billion in the nine months to end of September, according to data from Dealogic.
With just three months left until the end of 2020, banks are on course for their best year in more than a decade. Global M&A volumes surged to $1 trillion over the summer, according to data provider Refinitiv — the best third quarter since it started tracking numbers in 1998.
However, some lawyers and bankers cautioned that a rise in coronavirus infections could dampen deal making.
“Clearly there is great momentum to this deal activity, but another winter COVID spike with further lockdowns could slow the pace and push deals into 2021,” said Frank Aquila, global head of M&A at international law firm Sullivan & Cromwell.
Eamon Brabazon, co-head of EMEA M&A at Bank of America, said there was an “underlying fragility and nervousness” that something akin to a significant second COVID wave could happen. “If so, we would expect the recent positive learnings around virtual processes would mean that any impact on M&A would be less acute than otherwise”
Equity capital markets bankers were kept busy, as a stampede of companies took advantage of the rapid recovery in capital markets to sell their shares, with fees soaring by 73% on last year to $18.8 billion. So far this year, IPOs have raised $135.5 billion globally, 56% of which was unveiled in the third quarter, with health care, technology and blank-check companies (or special purpose acquisition vehicles — SPACS) dominating activity.
Investor demand for fast-growing companies was demonstrated by the IPO of Snowflake /zigman2/quotes/220991541/composite SNOW -5.97% . Stock in the data storage and analytics provider more than doubled on its market debut on Sept. 16.
In Europe, shares in The Hut Group soared more than 30% in the online health and beauty retailer’s first day of trading on Sept. 16 in London, as it swept away corporate governance concerns to become the U.K.’s biggest ever technology initial public offering.
Martin Steinbach, EY EMEIA global leader, said the demand for IPOs was being driven by investors looking for returns in a low interest rate environment. “If equity stories, management and balanced pricing are met — we predict this will bring a strong close to 2020,” he said, adding that the trend could accelerate as multinationals look to spin off divisions to focus on core businesses.
A series of emergency fundraisings by companies looking to shore up their finances when the pandemic hit in March also provided a big payday for debt capital markets bankers. DCM fees have surged by nearly 30% in the same period in 2019, to $22.9 billion.
Among those raising hundreds of billions of dollars were computer technology company Oracle /zigman2/quotes/202180826/composite ORCL +0.16% ($20 billion), U.S. oil major Exxon Mobil /zigman2/quotes/204455864/composite XOM -1.06% ($8.5 billion), and the world’s largest brewer Anheuser-Busch InBev /zigman2/quotes/209225053/composite BUD -2.77% ($5.0 billion).